{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:27:37Z","timestamp":1648704457878},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0666-7","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T09:42:25Z","timestamp":1500889345000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation"],"prefix":"10.1186","volume":"18","author":[{"given":"Kar Wah","family":"Fuah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Thiam Seong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"issue":"3","key":"666_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5414\/CNP69161","volume":"69","author":"P Marckmann","year":"2008","unstructured":"Marckmann P, Skov L, Rossen K, Thomsen HS. Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol. 2008 Mar;69(3):161\u20138.","journal-title":"Clin Nephrol"},{"issue":"4","key":"666_CR2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000372-200308000-00017","volume":"25","author":"SE Cowper","year":"2003","unstructured":"Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol. 2003;25(4):358.","journal-title":"Am J Dermatopathol"},{"key":"666_CR3","doi-asserted-by":"crossref","unstructured":"Cowper SE, Rabach M, Girardi M. Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol. 2008;66(2):191\u20139.","DOI":"10.1016\/j.ejrad.2008.01.016"},{"issue":"7","key":"666_CR4","first-page":"903","volume":"139","author":"WW Ting","year":"2003","unstructured":"Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy withsystemic involvement. Arch Dermatol. 2003;139(7):903\u20136.","journal-title":"Arch Dermatol"},{"key":"666_CR5","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMcpc049026","volume":"351","author":"SL Moschella","year":"2004","unstructured":"Moschella SL, Kay J, Mackool BT, Liu V. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35\u20132004. A 68-year-old man with end-stage renal disease and thickening of the skin. N Engl J Med. 2004;351:2219.","journal-title":"N Engl J Med"},{"key":"666_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","volume":"5","author":"P Joffe","year":"1998","unstructured":"Joffe P, Thomsen HS, Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol. 1998;5:491.","journal-title":"Acad Radiol"},{"key":"666_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.rli.0000253505.88945.d5","volume":"42","author":"A Khurana","year":"2007","unstructured":"Khurana A, Runge VM, Narayanan M, Greene JF Jr, Nickel AE. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (Omniscan). Investig Radiol. 2007;42:139\u201345.","journal-title":"Investig Radiol"},{"key":"666_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cmmi.146","volume":"2","author":"C Thakral","year":"2007","unstructured":"Thakral C, Alhariri J, Abraham JL. Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications. Contrast Media Mol Imaging. 2007;2:199\u2013205.","journal-title":"Contrast Media Mol Imaging"},{"issue":"3","key":"666_CR9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2215\/CJN.06580909","volume":"5","author":"C Chrysochou","year":"2010","unstructured":"Chrysochou C, Power A, Shurrab AE, et al. Low risk for Nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clin J Am Soc Nephrol. 2010;5(3):484\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"666_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2007.07.018","volume":"58","author":"N Elizabeth","year":"2008","unstructured":"Elizabeth N, Hu S, Leslie RB. Nephrogenic systemic fibrosis with septal panniculitis mimicking erythema nodosum. Am Acad Dermatol. 2008;58:149\u201350.","journal-title":"Am Acad Dermatol"},{"key":"666_CR11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2214\/AJR.07.2884","volume":"190","author":"LP Golding","year":"2008","unstructured":"Golding LP, Provenzale JM. Nephrogenic systemic fibrosis: possible association with a predisposing infection. AJR Am J Roentgenol. 2008;190:1069.","journal-title":"AJR Am J Roentgenol"},{"key":"666_CR12","unstructured":"The International Center for Nephrogenic Fibrosing Dermopathy Research \nhttp:\/\/www.icnfdr.org\n\n. Accessed 8 Jan 2017."},{"key":"666_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0303-6987.2004.00169.x","volume":"31","author":"LC Edsall","year":"2004","unstructured":"Edsall LC, English JC III, Teague MW, Patterson JW. Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J Cutan Pathol. 2004;31:247\u201353.","journal-title":"J Cutan Pathol"},{"key":"666_CR14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.0303-6987.2005.00365.x","volume":"32","author":"C Kucher","year":"2005","unstructured":"Kucher C, Xu X, Pasha T, Elenitsas R. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol. 2005;32:484.","journal-title":"J Cutan Pathol"},{"key":"666_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","volume":"35","author":"FA Mendoza","year":"2006","unstructured":"Mendoza FA, Artlett CM, Sandorfi N, et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum. 2006;35:238.","journal-title":"Semin Arthritis Rheum"},{"key":"666_CR16","unstructured":"U.S Food and Drug Administration. 2010. FDA Drug Safety Communication: New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. \nhttps:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm223966.htm\n\n. Accessed 24 Apr 2017."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T09:42:47Z","timestamp":1500889367000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0666-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0666-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"article-number":"249"}}